R. Labianca

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma.

R. Labianca, V. Torri, F. Landoni, 2003, European journal of cancer.

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

R. Labianca, A. Brandes, M. Reni, 2009, Cancer Chemotherapy and Pharmacology.

A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients

A. Falanga, L. Barcella, F. Petrelli, 2023, Cancers.

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.

S. Barni, R. Labianca, G. Luporini, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report.

G. Luporini, A. Zaniboni, G. Pancera, 1995, Cancer.